{"id":11852,"date":"2026-03-31T18:31:52","date_gmt":"2026-03-31T16:31:52","guid":{"rendered":"https:\/\/crcm-marseille.fr\/?p=11852"},"modified":"2026-03-31T18:43:22","modified_gmt":"2026-03-31T16:43:22","slug":"open-position-at-the-crcm","status":"publish","type":"post","link":"https:\/\/crcm-marseille.fr\/en\/crcm-articles\/open-position-at-the-crcm\/","title":{"rendered":"Position available at CRCM: Group Leader in Onco-Hematology \/ Immuno-Oncology"},"content":{"rendered":"\n

We are recruiting a Group Leader in Onco\u2011Hematology \/ Immuno\u2011Oncology<\/strong><\/h2>\n\n\n\n

The Cancer Research Center of Marseille (CRCM) is inviting applications for a Group Leader position to establish a new research team within the Onco\u2011Hematology and Immuno\u2011Oncology Department (OHIO<\/strong>)<\/a>. This position is intended to enhance our capability for basic science and\/or translational research capacity at the intersection of basic mechanisms, innovative therapies and clinical implementation in hematologic cancers and cancer immunology.<\/p>\n\n\n\n

With over 450 collaborators spread across four departments, including the OHIO Department, the CRCM is an international research center affiliated with Inserm, CNRS, Aix\u2011Marseille University and the Paoli\u2011Calmettes Cancer Institute (IPC<\/a><\/strong>). The CRCM brings together interdisciplinary teams working on oncogenesis, tumor microenvironment, immune responses to cancer and biomarker discovery. It works closely with the IPC, a nonprofit general hospital with recognized expertise in the field of hematologic malignancies and early-phase clinical trials of cutting-edge therapies.<\/p>\n\n\n\n

The appointed Group Leader will establish an innovative research program in onco\u2011hematology and\/or immuno\u2011oncology, emphasizing a robust fundamental\/translational aspects and seamless integration within the CRCM\u2013IPC ecosystem.<\/p>\n\n\n\n

The successful candidate will receive a start-up package and have a privileged access to cutting-edge technological platforms for multi-omics (including proteomics, single-cell, genomics, and spatial-omics), imaging and flow cytometry (including Immunomonitoring), drug screening and testing, and computational biology. The integrated CRCM\u2013IPC environment offers direct access to patient samples and cohorts, and early\u2011phase trials at IPC, providing a unique framework for ambitious translational research. <\/p>\n\n\n\n

The CRCM will provide engaged mentoring to the selected candidate to obtain a tenure position (CNRS or Inserm) and to secure extra funding (ATIPE\/Avenir, INCa, ANR, ERC etc..). Researchers with permanent positions are also invited to apply. <\/p>\n\n\n\n

Qualifications & Engagement<\/strong><\/p>\n\n\n\n